Cognitive impairment in schizophrenia represents one of the main obstacles to clinical and
functional recovery. This expert group paper brings together experts in schizophrenia …

Objectives: To determine the prevalence and correlates of treatment-resistant schizophrenia
(TRS) through a systematic review and meta-analysis. Methods: Following Preferred …

Abstract Treatment-Resistant Schizophrenia (TRS) represents a main clinical issue,
associated with worse psychopathological outcomes, a more disrupted neurobiological …

Background Cognitive dysfunction is a core feature of schizophrenia. Although treatment-
resistant schizophrenia (TRS) exhibits wide-ranging neuropsychological deficits, factors …

Purpose/Background: The favorable effect of clozapine on psychotic symptoms in patients
with treatment-resistant (TR) schizophrenia (SCZ) in short-term studies is well established …

Background Visual-spatial working memory (vsWM) impairment in treatment-resistant
schizophrenia (TRS) currently has no satisfactory treatment. Our study aimed to improve …

Methods: This study was conducted at the Institute of Mental Health, Singapore, and
included healthy controls and people with schizophrenia categorised into these groups …

Background Brain structural alterations and cognitive dysfunction are independent
predictors for poor clinical outcome in schizophrenia, and the associations between these …

The contribution of anticholinergic burden to cognitive function in patients with treatment
resistant schizophrenia (TRS) is uncertain. This case-control study aims to comprehensively …

Background/Objectives: Cognitive impairment is a core feature of schizophrenia, affecting
attention, memory, and executive function and contributing significantly to the burden of the …